Related Experiment Video
Updated: Aug 13, 2026

Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
Cognitive, affective, and behavioral side events in adults secondary to antiepileptic drug use
1Department of Neurology, Yale University School of Medicine, New Haven, CT, USA.
Abstract:
Antiepileptic drugs (AEDs) may contribute to and aggravate problems of cognition, mood, and behavior in some patients. The frequency and severity of the psychological disturbances are difficult to determine because many factors confound the interpretation of evidence whether it results from open case reports, controlled clinical trials, or neuropsychological testing. Concern about potential problems should not preclude trying an AED if other properties make the agent otherwise appropriate because the occurrence of adverse effects is often unpredictable in any given individual. Impairment can be minimized by gradual titration of dose and limiting total dose as clinically possible. If psychological problems arise and fine titration of the AED cannot eliminate the problem, the drug can be discontinued without permanent life threatening sequellae.
Related Concept Videos
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

